
The MCS group at IQAC-CSIC carries out chemical research to obtain new therapeutic approaches by combining the improvement and optimization of compounds with the development of new technologies that can be transferred to the company.
Consejo Superior de Investigaciones Científicas (CSIC)
Photopharmacology; protein labeling; organic synthesis; pharmacology; analysis; photochemistry; drug; medicinal chemistry; biomolecules; biomolecular mechanisms; industrial chemistry; chromatographic techniques; pharmaceutical production; preclinical research
Want more information about TECNIO Technology Developers?
Technological capabilities
- Design, synthesis and chemical/pharmacological photocharacterization of photoreversible and photolabile compounds. We have extensive experience in the design and synthesis of these compounds as biological tools and drugs for Medical Chemistry projects. We specialize in the characterization of photochemical and photopharmacological properties.
- Covalent labeling of native proteins with chemical methods. We offer expertise in the covalent modification of native proteins, without chemical or genetic alterations, for biological and diagnostic applications.
- Medical Chemistry/Process Chemistry and Synthesis on demand with analytical support that makes a difference. We have experience in medicinal and biological chemistry for the synthesis of compounds in the pre-clinical phase, as well as in advising research groups, biotech companies and start-ups without resources for drug discovery.
- In addition, we have extensive knowledge in improving industrial drug synthesis processes and have non-conventional analytical instrumentation to guarantee precision and reliability in compound analysis.
Technological fields

Biotechnology, Design new drugs / vaccines
Relevant equipment
We have a laboratory with controlled lighting conditions, which contains optical instruments and a microplate reader essential for carrying out research in Photopharmacology under controlled lighting conditions.
MCS location
